.png){kind=icon}
Return
Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8+ T Cell Responses
.png){kind=icon}
OA
AI
DOI：10.1016/j.immuni.2019.01.010.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Systemic immunosuppression greatly affects the chemotherapeutic antitumor effect. Here, we showed that CD19(+) extracellular vesicles (EVs) from B cells through CD39 and CD73 vesicle-incorporated proteins hydrolyzed ATP from chemotherapy-treated tumor cells into adenosine, thus impairing CD8(+) T cell responses. Serum CD19(+) EVs were increased in tumor-bearing mice and patients. Patients with fewer serum CD19+ EVs had a better prognosis after chemotherapy. Upregulated hypoxia-inducible factor-1 alpha (HIF-1 alpha) promoted B cells to release CD19(+) EVs by inducing Rab27a mRNA transcription. Rab27a or HIF-1 alpha deficiency in B cells inhibited CD19(+) EV production and improved the chemotherapeutic antitumor effect. Silencing of Rab27a in B cells by inactivated Epstein-Barr viruses carrying Rab27a siRNA greatly improved chemotherapeutic efficacy in humanized immunocompromised NOD Prkdc(scid) Il2rg(-/-) mice. Thus, decreasing CD19(+) EVs holds high potential to improve the chemotherapeutic antitumor effect.
Keywords:
ADENOSINE
CANCER
CD73
LYMPHOCYTES
GENERATION
PROTECTS
EXOSOMES
CD39
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
26.3
Papers:
6.4K
Citations:
7.5W
Organization
Cited Papers
ShareSaveRab27a and Rab27b control different steps of the exosome secretion pathway.png)
NATURE CELL BIOLOGYOAAI
NATURE CELL BIOLOGYIF19.1
OAAIShareSaveShareSaveShareSaveInhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signalingCANCER RESEARCHOAAI
CANCER RESEARCHIF16.6
OAAIShareSaveShareSaveShareSave
View more